Reaction

Sleep Disorder Due To General Medical Condition, Hypersomnia Type reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 99 reports · 29 co-occurring drugs

As of the last recalculation, Sleep Disorder Due To General Medical Condition, Hypersomnia Type appears in 99 FAERS reports alongside 29 co-occurring drug terms. The strongest observed disproportionality signal is DICLOFENAC POTASSIUM, FILM COATED (PRR 975.0).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Diclofenac Potassium, Film Coated	28	975.0	978.3
Diclofenac Potassium Tablets	28	974.3	977.6
Diclofenac Potassium	28	759.2	761.2
Pseudoephedrine Hydrochloride	24	647.9	649.4
Pseudoephedrine Hcl	24	604.2	605.5
Moxifloxacin Hydrochloride	29	424.9	425.5
Naproxen Sodium Tablet, Coated	20	388.9	389.5
Naproxen Sodium, Coated Tablets	20	388.9	389.5
Naproxen Sodium 220Mg	20	388.3	388.9
Moxifloxacin	20	373.8	374.3
Desoximetasone	24	349.3	349.7
Triamcinolone Acetonide Ointment Usp, 0.05%	26	316.3	316.6
Quetiapine Fumarate	30	306.2	306.5
Diclofenac Sodium 1%	34	304.2	304.5
Diclofenac Sodium Topical	34	304.2	304.5
Diclofenac Sodium Topical Gel, 1%	34	303.6	303.9
Cortisone Acetate	15	300.9	301.2
Cetirizine Hydrochloride Allergy	29	284.3	284.6
Cetirizine Hydrochloride Tablets	29	284.3	284.6
Triamcinolone Acetonide	26	239.6	239.8
Oxycodone And Acetaminophen Tablets	10	196.1	196.3
Doxyclycline Hyclate	13	184.6	184.8
Acetaminophen And Codeine	9	170.7	170.9
Golimumab	33	120.8	120.9
Sarilumab	13	119.0	119.0
Botulinum Toxin Type A	6	108.1	108.1
Tofacitinib Citrate	6	102.4	102.4
Ustekinumab	32	96.7	96.7
Apremilast	28	55.7	55.7

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.